Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
出版年份 2018 全文链接
标题
Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-10-09
DOI
10.3389/fphar.2018.01097
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Design, synthesis and anticancer studies of novel aminobenzazolyl pyrimidines as tyrosine kinase inhibitors
- (2018) Rupesh Chikhale et al. BIOORGANIC CHEMISTRY
- Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters
- (2018) Ying-Fang Fan et al. CANCER LETTERS
- Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors
- (2018) Mahaveer Singh et al. DRUG DISCOVERY TODAY
- Recent advances in the discovery of small molecule c-Met Kinase inhibitors
- (2018) Palak K. Parikh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis
- (2018) Lina Tang et al. OncoTargets and Therapy
- Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
- (2017) Giovanni Luca Beretta et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 2-Trifluoromethyl-2-Hydroxypropionamide Derivatives as Novel Reversal Agents of ABCG2 (BCRP)-Mediated Multidrug Resistance: Synthesis and Biological Evaluations
- (2017) Rishil J. Kathawala et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Structure of the human multidrug transporter ABCG2
- (2017) Nicholas M. I. Taylor et al. NATURE
- Receptor tyrosine kinase expression and phosphorylation in canine nasal carcinoma
- (2017) Samuel E. Hocker et al. RESEARCH IN VETERINARY SCIENCE
- Targeting receptor tyrosine kinase EphB4 in cancer therapy
- (2017) Yinnan Chen et al. SEMINARS IN CANCER BIOLOGY
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Olmutinib: First Global Approval
- (2016) Esther S. Kim DRUGS
- Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells
- (2016) Xiao-Yu Zhang et al. MOLECULES
- Mechanisms of drug resistance in colon cancer and its therapeutic strategies
- (2016) Tao Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters
- (2016) Yun-Kai Zhang et al. Scientific Reports
- Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients
- (2015) Xueqin Chen et al. Cancer Cell International
- Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance
- (2015) W. Miklos et al. CANCER LETTERS
- Variability in bioavailability of small molecular tyrosine kinase inhibitors
- (2015) Maikel Herbrink et al. CANCER TREATMENT REVIEWS
- Molecular mechanisms of drug resistance and its reversal in cancer
- (2015) Melis Kartal-Yandim et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agents
- (2015) Yun-Kai Zhang et al. Oncotarget
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
- (2014) Qiong Wu et al. CANCER LETTERS
- Unknown
- (2014) Shao-lin Ma et al. MOLECULAR MEDICINE
- Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
- (2014) Nagaraju Anreddy et al. MOLECULES
- Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters
- (2013) J. Jacob Strouse et al. ANALYTICAL BIOCHEMISTRY
- Different strategies to overcome multidrug resistance in cancer
- (2013) Manju Saraswathy et al. BIOTECHNOLOGY ADVANCES
- Acidic extracellular microenvironment and cancer
- (2013) Yasumasa Kato et al. Cancer Cell International
- Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy
- (2012) Dariusz Pytel et al. Anti-Cancer Agents in Medicinal Chemistry
- Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
- (2012) Suneet Shukla et al. DRUG RESISTANCE UPDATES
- Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome
- (2010) Motofumi Tanaka et al. CANCER
- Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
- (2010) Zhanglin Ni et al. CURRENT DRUG METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started